Post Blogs, Photos, Youtube, Vimeo Videos, Topics, Events, Groups.
+ Larger Font | - Smaller Font
Share
avatar

swati bis

Social

Photos

Recent Activities

  • swati bis created a new blog entry
    Lung Cancer Genomic Testing Market is Expected to Reach $3,279.8 million by 2031
    The global lung cancer genomic testing market is still in the nascent phase. Various companies are increasing investments in research and development to fa...
    on May 13 at 6:56 . Comment   0 0
  • swati bis created a new blog entry
    Digital Biomarkers Market Will Generate Massive Revenue By 2028
    Healthcare is undergoing a technological transformation, as companies are leveraging new technologies to generate, collect, and track novel data. With the ...
    on May 12 at 10:41 . Comment   0 0
  • swati bis
    Middle East Precision Medicine Market-Analysis and Forecast, 2022-2032

    The Middle East precision medicine market was estimated to be at $3,942.6 million in 2021, which is expected to grow with a CAGR of 7.37% and reach $8,620.0 million by 2032.
    https://bisresearch.com/industry-report/middle-east-precision-medicine-market.html
    on May 12 at 6:37 . Comment   0 0
  • swati bis
    Non-Oncology Precision Medicine Market is Estimated to reach $129.96 Billion in 2030
    The global non-oncology precision medicine market was valued at $41.1 in 2019, and it is expected to grow at an impressive double-digit rate of 11.03% and reach a value of $129.96 in 2030.
    https://bisresearch.com/industry-report/non-oncology-precision-medicine-market.html
    on May 11 at 8:07 . Comment   0 0
  • swati bis created a new blog entry
    Axial Spondyloarthritis Market is Set to Reach $7,937.8 Million by 2032
    The global axial spondyloarthritis market is well established. Biopharmaceutical companies are trying to match themselves with new technologies in the mark...
    on May 10 at 6:50 . Comment   0 0
  • swati bis
    Axial Spondyloarthritis Market is Set to Reach $7,937.8 Million by 2032
    The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.

    https://bisresearch.com/industry-report/axial-spondyloarthritis-market.html
    on May 10 at 6:41 . Comment   0 0
  • swati bis created a new blog entry
    BIS Research Report Highlights the Global Precision Medicine Market to Reach $278.61 Billion by 2030
    Theglobal precision medicine marketis projected to reach$278.61 billionby 2030, reveals a premium market intelligence report by BIS Research. The study als...
    on May 9 at 7:19 . Comment   0 0
  • swati bis created a new blog entry
    Precision Medicine Market to Reach $141.70 Billion by 2026, Reports BIS Research
    According to a new market intelligence report by BIS Research, titled"Global Precision MedicineMarket-Analysis and Forecast, 2017-2026", the global precisi...
    on May 9 at 6:01 . Comment   0 0
  • swati bis
    Precision Medicine Market to Reach $141.70 Billion by 2026, Reports BIS Research
    The global precision medicine market is expected to be $141.7 billion by 2026. The market growth is attributed to the adoption of early stage treatments, increased number of adverse drug reactions cases, prevalence of chronic diseases, and advancement in genetic science, among others. Technologies such as gene sequencing, companion diagnostics, pharmacogenomics, bioinformatics, and big data analytics are expected to drive the market growth during the forecast period. The countries such as Spain, Italy, Singapore, India, China, KSA, the U.A.E. and Brazil offer several untapped and unexplored opportunities for the growth of this market.
    https://bisresearch.com/industry-report/global-precision-medicine-market-2026.html
    on May 9 at 5:59 . Comment   0 0
  • swati bis created a new topic
    Global Precision Medicine Market to Reach $216.75 Billion by 2028
    According to a new market intelligence report by BIS Research, titled'Global Precision Market - Analysis and Forecast, 2018-2028', the global precision medic...
    on May 6 at 1:21 . Comment   0 0
  • swati bis created a new topic
    Big Data in Healthcare Market is Expected to Reach $130.1 billions by 2031
    Big data is one of the subjects of interest since it has the potential to transform modern healthcare. The technology has grown substantially over the last...
    on May 5 at 2:18 . Comment   0 0
  • swati bis
    Big Data in Healthcare Market is Expected to Reach $130.1 billions by 2031
    Big data is one of the subjects of interest since it has the potential to transform modern healthcare. The technology has grown substantially over the last two decades. Many healthcare companies have begun to leverage big data for a variety of applications, such as developing products, improving patient outcomes, and driving innovation, among others.

    The adoption of big data in healthcare is still at a nascent stage despite being a large market. The growth of the market is expected to be significantly boosted by the growing demand for evidence-based clinical care in developing countries. Technological advancements anticipated from 2022 to 2031 are expected to play a crucial role in deciding the future of the big data in healthcare market and the level of adoption.

    The global big data in healthcare market report highlights that the market was valued at $32,925.1 million in 2021 and is expected to reach $130,132.1 million by the end of 2031. The market is expected to grow at a CAGR of 13.96% during the forecast period 2022-2031.

    Market Segmentation

    Global Big Data in Healthcare Market (Components and Services)

    The global big data in healthcare market, based on components and services, has been segmented into hardware, software, and analytics services. Hardware in big data refers to components whose aim is to provide security and storage to protected health information (PIH) of the patients through compliance with data protection regulations. The healthcare industry is evolving, and therefore, more treatments will depend on networks, more devices will be connected, more information will be transferred, collected, and analyzed.

    Healthcare organizations expect that big data analytics will help them minimize costs and improve the quality of care. Big data analytics in healthcare helps to detect diseases at earlier stages and healthcare frauds rapidly.

    Global Big Data in Healthcare Market (by Use Case)

    The global big data in healthcare market, based on use case, has been segmented into clinical data analytics, financial analytics and operational analytics. Clinical data analytics extracts data from EHRs and health information exchange to analyze patient populations and proactively provide quality care to them. The importance of clinical data analytics is increasing as healthcare systems are capturing bigger and better data sets. Clinical analytics primarily uses retrospective analysis rather than real-time clinical decision support.

    Global Big Data in Healthcare Market (by End User)

    The global big data in healthcare market, based on end user, has been segmented into professional healthcare settings, healthcare companies and consultancies, government agencies/bodies, finance and insurance agencies, and academic and research institutes.

    The increase in focus on evidence-based care has been one of the strongest drivers of the adoption of big data in healthcare. Big data analytics allows hospitals and healthcare providers to identify the risk before any major complication occurs and reduces the cost of care. Some of the factors that hinder the adoption of these digital solutions are patient privacy, as there have been some complications in sharing patient information with healthcare professionals.

    Furthermore, many industries such as finance and insurance agencies are making a shift toward the use of big data for analyzing the data. Finance and insurance agencies are also shifting toward digital platforms. The adoption of big data in healthcare insurance companies has been subject to digitizing the information and understanding the complex behavioral patterns of the customer.

    Global Big Data in Healthcare Market (by Mode of Deployment)

    The global big data in healthcare market, based on the mode of deployment, has been segmented into on-premises and cloud-and web-based. On-premises mode of deployment refers to the model built natively into the electronic health records (EHRs) of hospitals and other professional healthcare facilities. On-premises models are currently more preferred over their cloud-based counterparts.

    In addition, the cloud-and web-based systems are more flexible and secure and allow users to have control over the data center. The data encryption techniques isolate and protect sensitive data to prevent leaks during data transmission.

    Global Big Data in Healthcare Market (by Region)

    The different regions covered under the global big data in healthcare market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

    The U.S is the dominant market in North America, considering its well-developed healthcare infrastructure and healthcare reforms such as the Affordable Care Act (ACA) and HITECH Act. The Asia-Pacific big data in healthcare market is one of the lucrative markets with immense potential for expansion by key players in the global big data in healthcare market. The healthcare sector is getting more attention than in the past. Countries such as India and China have several digital health initiatives which have witnessed accelerated implementation during the COVID-19 pandemic.

    Key Market Players and Competition Synopsis

    Some key players operating in the market include Active Health Management, Allscripts Healthcare Solutions, Inc., Cerner Corporation, Epic Systems Corporation, eClinical Works, General Electric Company, Siemens Healthineers AG, JLL Partners, Verana Health, ConcertAI, LynxCare, Abacus Insights, Milagro AI, Datavant, and Clarify Health Solutions.

    Some strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, business expansion, and new offerings.

    Key Questions Answered in the Report

    • How has COVID-19 impacted the growth of the global big data in healthcare market?
    • What are the key regulations governing the big data in healthcare market in key regions?
    • Which technological developments are projected to have the maximum influence on the global big data in healthcare market?
    • Who are the leading players holding significant dominance in the global big data in healthcare market?
    • What are some of the growth opportunities which market players can capitalize on?
    • What are the drivers and restraints for the global big data in healthcare market?
    • Which region has the highest growth rate in the big data in healthcare market?
    • Which are the fastest growing countries in terms of the global big data in healthcare market?
    • What are the key strategies being adopted by market players in the global big data in healthcare market?
    • Which are the emerging companies in the global big data in healthcare market?

    Request Sample - https://bisresearch.com/requestsample?id=1230&type=download

    How This Report Can Add Value

    Who should buy this report and why?

    Assuming that the reader is a vendor in big data in healthcare market, the report will assist them in the following ways:

    • Understand their position compared to other key players in the market
    • Stay updated with the latest developments in the market
    • Understand the impact of COVID-19 on big data in healthcare and the entry barriers for new companies
    • Gain insights into end-user perception concerning the big data in healthcare market
    • Identify key players in the market and understand their valuable contribution
    • Understand the key growth areas and regions to target for market expansion

    BIS Related Studies

    Global AI in Healthcare Market

    Global Clinical Decision Support Systems (CDSS) Market
    on May 5 at 2:04 . Comment   0 0
  • swati bis created a new topic
    Blood and Plasma Components Market is Expected to Reach $66.47 Billion in 2031
    The global blood and plasma components market is expected to witness minimal growth, attributing to the rising burden of primary immunodeficiency diseases ...
    on May 5 at 6:57 . Comment   0 0
  • swati bis created a new topic
    The global single cell bioinformatics software and services market was estimated to be at $205.2 million in 2020, which is expected to grow with a CAGR of 10.89% and reach $634.8 million by 2031.
    The single cell bioinformatics software and services market is still in the nascent phase. Significant increases in the research and development activities...
    on April 28 at 11:49 . Comment   0 0
  • swati bis created a new topic
    Single Cell RNA Sequencing Market is Anticipated to Reach a Value of $2,931.3 million in 2031
    The single cell RNA sequencing technology is developed to detect genome, transcriptome and other multi-omics of single cells. It has an advantage of analyz...
    on April 26 at 8:22 . Comment   0 0
  • swati bis created a new topic
    Europe Infectious Disease Diagnostics Market Witnessing High Growth with CAGR of 16.48% till 2031
    The use of infectious disease diagnostics kits, assays, and other consumables has increased due to the rising prevalence of cancer, the increasing key play...
    on April 25 at 6:41 . Comment   0 0
  • swati bis created a new blog entry
    Bio-Isobutene Market is Set to have Exponential Growth with CAGR of 150.30% till 2025
    The global bio-isobutene market growth is mainly attributed to the increased demand for bio-based and green products in multiple application areas such as ...
    on April 22 at 8:52 . Comment   0 0
  • swati bis created a new topic
    Data Center Liquid Cooling Market is Expected to Reach $7.7 billion by 2026, at a CAGR of 27.31%
    Liquid cooling was initially designed for supercomputers during the 1960s. IBM utilized liquid cooling for its System360 mainframe computers; however, it w...
    on April 22 at 6:21 . Comment   0 0
  • swati bis created a new topic
    Carbon Neutral Data Center Market Size to Hit $9.42 Billion by 2025, At a CAGR of 22.17%
    The carbon neutral data center market by industry has the largest share in the IT and telecom industry, followed by the BFSI industry. The IT and telecom i...
    on April 21 at 1:32 . Comment   0 0
  • swati bis created a new topic
    Gene Cloning Services Market Size to Hit $11.5 billion by 2031, at a CAGR of 17.29%
    Gene cloning is an essential part of medical decision-making and aid in acquiring information for a wide range of treatment dissemination, accentuating its...
    on April 21 at 5:32 . Comment   0 0
  • swati bis created a new topic
    Acellular Therapy Market - Strategies and Applications
    Stem cell research has made remarkable progress, laying a strong foundation for its use in regenerative medicine applications of wounded or diseased tissue...
    on April 20 at 11:32 . Comment   0 0
  • swati bis created a new topic
    Oncology Precision Medicine Market Insight , Industry Analysis & Future Outlook 2031
    Precision medicine is a concept that collectively integrates the outcomes and the endeavors of research and healthcare. The ability to tailor the diagnosti...
    on April 6 at 10:50 . Comment   0 0
  • swati bis created a new topic
    Plasma Medicine Market - Strategies and Implementation
    The technological revolution in the past two decades has produced an unprecedented number of assets to propel future innovations. The current plasma medici...
    on April 5 at 12:23 . Comment   0 0
  • swati bis


    Radioligand Therapy Market

    Radioligand therapeutics, also known as radiopharmaceuticals, which show antitumor effects, has seen rapid development over the past decade. Although some therapies are already approved for human use, many more are in the clinical trial and will enter clinical practice in the next 2-7 years, potentially introducing new therapeutic choices for patients. Despite this innovation, several challenges remain, including supply chain, logistics, regulatory issues, and education and training. The current market for radioligand therapy is majorly dominated by manufacturers such as Novartis AG, Pfizer Inc, Johnson & Johnson Services, Inc, Telix Pharmaceuticals, Lantheus Holdings Inc., (Progenics Pharmaceuticals), Molecular Partners AG, Clovis Oncology Inc., Fusion Pharma, Point Biopharma, Precirix, ITM Isotope Technologies Munich SE, Curium Pharma, and RadioMedix. The global radioligand therapy market was valued at $9,754.9 million in 2020 and is expected to reach $16,658.4 million by 2031, witnessing a CAGR of 4.67% during the forecast period 2021-2031.

    Competitive Landscape

    The global radioligand therapy market comprises well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the innovation in radioligand therapy from different sample types. Key market players of the global radioligand therapy market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-February 2022. The inclination of companies toward product launches and product approval suggests that the companies are involved in continuously bringing new products to the market to radioligand therapy, which is primarily attributed to a rising prevalence of cancer, rising clinical research activity, and rising key players' initiatives are driving the market.

    Global Radioligand Therapy Market Segmentation

    • Product (Approved Products and Potential Pipeline)

    • Indication (Prostate Cancer, Neuroendocrine Tumor (NETs), and Others)

    • Biomarker (Prostate-Specific Membrane Antigen, Ki 67 Expression and Grading, Cytochrome P450 17A1 Inhibitor)

    Regional Segmentation

    • North America - U.S., Canada

    • Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe

    • Asia-Pacific - Japan, South Korea, Australia, and Rest-of-Asia-Pacific

    • Rest-of-the-World

     

    Market Growth Drivers

    • Radioligand Therapy Demand Inclined by Rising Prevalence of Cancer

    • Strategic Initiatives by Key Market Players

    • Rise in Clinical Research Activity

    Market Challenges

    • High Cost Associated with Treatment and Complex Reimbursement Processes

    • Increased Competition from Generics

    Market Opportunities

    • Expanding Radiopharmaceutical Coverage

    • Role of Radioligand in Drug Discovery

    Key Companies Profiled

    Johnson & Johnson Services, Inc., Pfizer Inc., Amneal Pharmaceuticals LLC, Novartis International AG, POINT Biopharma Global Inc, Fusion Pharma, Clovis Oncology, Telix Pharmaceuticals, Lantheus Holdings, Inc. (Progenics Pharmaceuticals), Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Curium Pharma, Precirix, Radio Medix

    Key Questions Answered in this Report:

    • How is radioligand therapy revolutionizing oncology?
    • What are the major market drivers, challenges, and opportunities in the global radioligand therapy market?
    • What are the underlying structures resulting in the emerging trends within the global radioligand therapy market?
    • How is the COVID-19 pandemic impacting the global radioligand therapy ecosystem?
    • What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
    • What are the key regulatory implications in developed and developing regions pertaining to the use of radioligand-targeted therapies?
    • What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
    • How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
    o Products (Approved Products and Potential Pipeline)
    o Indication (Prostate Cancer, Neuroendocrine Tumor (NETs), and Others)
    o Biomarker (Prostate-Specific Membrane Antigen, Ki 67 Expression and Grading, Cytochrome P450 17A1 Inhibitor)
    o Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
    • What are the growth opportunities for the radioligand therapy companies in the region of their operation?
    • Who are the leading players with significant offerings in the global radioligand therapy market?
    • Which companies are anticipated to be highly disruptive in the future, and why?

    Request Sample - https://bisresearch.com/requestsample?id=1280&type=download

    The scope of the report exclusively covers manufacturers offering proprietary radioligand therapy for target indications such as prostate cancer and neuroendocrine tumors. The study considers products based on various radioisotopes underlying applications in oncology to detect biomarkers and treatment of cancers. Moreover, the study considers the generics sales of Zytiga. 
    on April 5 at 7:03 . Comment   0 0
    • Load More


Become a member and experience a unique opportunity to post blogs, photos, Youtube Vimeo videos, topics, events, and create groups on Robin's Social Networking Site. Use Robin's Social to sell products, services and market your business when posting blogs.

By registering and posting content, you agree to the terms listed at... Posting Terms and Conditions. Enjoy!

© 2022 Content By Members. All Rights Reserved.